Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-N188 PET Imaging in Urothelial Carcinoma
NCT05321316Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of gallium Ga 68 N188 in urothelial carcinoma (UC), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Standardized uptake value at 2 years. Started May 2026; status: recruiting.
02
Drugs
gallium Ga 68 N188
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT05321316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05321316.